Evaluation of Efficacy and Safety of Ponatinib as Third-line Treatment in Patients with the Diagnosis of Chronic Phase Chronic Myeloid Leukemia

Articles > Article · 2016

Authors: PUSEM PATIR

International Journal of Hematology and Oncology, International, WoS, 2016, vol 26, pp 224-226